Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors
Katharina Lechner, Clemens von Schacky, Amy L. McKenzie, et al.
European Journal of Preventive Cardiology (2019) Vol. 27, Iss. 4, pp. 394-406
Open Access | Times Cited: 276

Showing 1-25 of 276 citing articles:

NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper, Anna Martin, Sonja Lang, et al.
Clinical Research in Cardiology (2020) Vol. 110, Iss. 7, pp. 921-937
Open Access | Times Cited: 461
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation
Francisco López-Jiménez, Wael Almahmeed, Harold Bays, et al.
European Journal of Preventive Cardiology (2022) Vol. 29, Iss. 17, pp. 2218-2237
Open Access | Times Cited: 168
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7910-7910
Open Access | Times Cited: 100
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Stamatios Lampsas, Maria Xenou, Evangelos Oikonomou, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 969-969
Open Access | Times Cited: 64
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
Katharina Lechner, Amy L. McKenzie, Nicolle Kränkel, et al.
Metabolic Syndrome and Related Disorders (2020) Vol. 18, Iss. 4, pp. 176-185
Open Access | Times Cited: 114
Inflammation and Cardiovascular Disease: The Future
Natalie Arnold, Katharina Lechner, Christoph Waldeyer, et al.
European Cardiology Review (2021) Vol. 16
Open Access | Times Cited: 71
A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
European Heart Journal (2021) Vol. 42, Iss. 47, pp. 4807-4817
Open Access | Times Cited: 69
There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
Michael E. Makover, Michael D. Shapiro, Peter P. Tóth
American Journal of Preventive Cardiology (2022) Vol. 12, pp. 100371-100371
Open Access | Times Cited: 57
The Effects of Porphyromonas gingivalis on Atherosclerosis-Related Cells
Jiaqi Zhang, Mengru Xie, Xiaofei Huang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 55
Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
Marija Branković, Igor Jovanović, Marija Dukić, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5146-5146
Open Access | Times Cited: 40
The impact of type 2 immunity and allergic diseases in atherosclerosis
Nieves Fernández‐Gallego, Raquel Castillo‐González, Nerea Méndez‐Barbero, et al.
Allergy (2022) Vol. 77, Iss. 11, pp. 3249-3266
Open Access | Times Cited: 40
Novel Insights into the Molecular Mechanisms of Atherosclerosis
Armanda Wojtasińska, Weronika Frąk, Wiktoria Lisińska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13434-13434
Open Access | Times Cited: 39
Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
Hernán Paublini, Ángel Arturo López‐González, Carla Busquets-Cortés, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2105-2105
Open Access | Times Cited: 29
Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy
Yanhong Pan, Weipeng Wu, Xiaoxin Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114817-114817
Open Access | Times Cited: 27
Puerarin alleviates atherosclerosis via the inhibition ofPrevotella copriand its trimethylamine production
Z H Li, Jun Weng, Jing‐Kun Yan, et al.
Gut (2024) Vol. 73, Iss. 12, pp. 1934-1943
Closed Access | Times Cited: 11
VAMP8 as a biomarker and potential therapeutic target for endothelial cell dysfunction in atherosclerosis
Luqun Yang, Xin Guan, Jiangwei Cheng, et al.
Gene (2025), pp. 149231-149231
Closed Access | Times Cited: 1
Diet and Lifestyle Factors and Risk of Atherosclerotic Cardiovascular Disease—A Prospective Cohort Study
Stefan Acosta, Anna Johansson, Isabel Drake
Nutrients (2021) Vol. 13, Iss. 11, pp. 3822-3822
Open Access | Times Cited: 41
Modulation of mTOR Signaling in Cardiovascular Disease to Target Acute and Chronic Inflammation
Madlen Kaldirim, Alexander Lang, Susanne Pfeiler, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 36
Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis
Haikun Liu, Geoffrey A. Pietersz, Karlheinz Peter, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects
Shitian Guo, Yu Zhou, Xiaojie Xie
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113775-113775
Open Access | Times Cited: 29
Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries
Karl Aramouni, Roland Assaf, Maria Azar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis
Puneetpal Singh, Nitin Kumar, Monica Singh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 261-261
Open Access | Times Cited: 19
The Influence of Polyphenols on Atherosclerosis Development
Agnieszka Ziółkiewicz, Kamila Kasprzak‐Drozd, Robert Rusinek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7146-7146
Open Access | Times Cited: 16
Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management
Vasiliki Katsi, Ilias Papakonstantinou, Konstantinos Tsioufis
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11786-11786
Open Access | Times Cited: 16
Key lifestyles and health outcomes across 16 prevalent chronic diseases: A network analysis of an international observational study
Jiaying Li, Dyt Fong, Kris Yuet Wan Lok, et al.
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top